Vaccinex Inc VCNX:NASDAQ

RT Quote | NASDAQ | USD
Last | 4:00 PM EDT
2.14quote price arrow down-0.10 (-4.46%)
Volume
95,113
52 week range
1.63 - 9.56
Loading...
  • Open2.22
  • Day High2.24
  • Day Low2.12
  • Prev Close2.24
  • 52 Week High9.56
  • 52 Week High Date02/19/21
  • 52 Week Low1.63
  • 52 Week Low Date09/29/20

Key Stats

  • Market Cap65.91M
  • Shares Out30.80M
  • 10 Day Average Volume0.09M
  • Dividend-
  • Dividend Yield-
  • Beta1.71
  • YTD % Change3.38

KEY STATS

  • Open2.22
  • Day High2.24
  • Day Low2.12
  • Prev Close2.24
  • 52 Week High9.56
  • 52 Week High Date02/19/21
  • 52 Week Low1.63
  • 52 Week Low Date09/29/20
  • Market Cap65.91M
  • Shares Out30.80M
  • 10 Day Average Volume0.09M
  • Dividend-
  • Dividend Yield-
  • Beta1.71
  • YTD % Change3.38

RATIOS/PROFITABILITY

  • EPS (TTM)-1.19
  • P/E (TTM)-1.79
  • Fwd P/E (NTM)-1.86
  • EBITDA (MRQ)-26.345M
  • ROE (MRQ)-
  • Revenue (MRQ)1.48M
  • Gross Margin (MRQ)42.24%
  • Net Margin (MRQ)-1,880.81%
  • Debt To Equity (MRQ)21.39%

EVENTS

  • Earnings Date11/11/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Vaccinex Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Vaccinex Inc. is a clinical-stage biotechnology company. The Company is engaged in the discovery and development of targeted biotherapeutics to treat diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate, pepinemab (VX15/2503), is a humanized monoclonal antibody that binds and blocks the signaling activity of SEMA4D. The Company’s pipeline products include pepinemab COMBO with...
Address
1895 Mount Hope Ave
Rochester, NY
14620-4540
United States

Top Peers

SYMBOLLASTCHG%CHG
TCON
TRACON Pharmaceuticals Inc
4.01-0.39-8.86%
AKTX
Akari Therapeutics PLC
1.69-0.04-2.31%
RZLT
Rezolute Inc
7.55-0.25-3.21%
ONTX
Onconova Therapeutics Inc
3.81-0.16-4.15%
CLBS
Caladrius Biosciences Inc
1.18-0.03-2.48%
SYN
Synthetic Biologics Inc
0.4606-0.0296-6.0384%